Document is current
Any future updates will be listed below
-
Authors
Schneider-Poetsch, Tilman https://orcid.org/0009-0005-5829-1319
Yoshida, Minoru https://orcid.org/0000-0002-4376-5674
Ito, Takuhiro https://orcid.org/0000-0003-3704-5205
Iwasaki, Shintaro https://orcid.org/0000-0001-7724-3754
-
Funding
Funding for this research was provided by:
Ministry of Education, Culture, Sports, Science and Technology (JP23H04882)
MEXT | Japan Society for the Promotion of Science (JP23H05473)
MEXT | Japan Society for the Promotion of Science (JP23H05473)
- License Information
-
More Information
Article History
Received: 26 August 2025
Accepted: 11 August 2026
First Online: 25 September 2026
Ethics
Competing interests: S.I. is a member of the Scientific Reports editorial board, an associate editor of The Journal of Biochemistry , and a paid consultant of Eisai. M.Y. serves as associate editor of Cancer Science and review editor of The Journal of Antibiotics . He is the cofounder of the venture company ‘EpiFrontier Therapeutics’. The remaining authors declare no competing interests.
